These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2840381)

  • 1. The effect of low-dose naloxone infusion on plasma ACTH and LH in patients with Cushing's and Addison's diseases.
    Moreira AC; Foss MC; Iazigi N; Verissimo JM
    Horm Metab Res; 1988 Apr; 20(4):230-4. PubMed ID: 2840381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
    J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of naloxone on plasma adrenocorticotropin levels and beta-endorphin-like immunoreactivity in bilaterally adrenalectomized patients with Cushing's disease and in Addison's disease.
    Kasperlik-Załuska A; Jeske W; Migdalska B; Soszyński P; Wiśniewska-Woźniak T
    Acta Med Pol; 1986; 27(3-4):131-9. PubMed ID: 2833071
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive rate-sensitive corticosteroid feedback mechanism of ACTH secretion in Cushing's disease.
    Fehm HL; Voigt KH; Kummer G; Pfeiffer EF
    J Clin Invest; 1979 Jul; 64(1):102-8. PubMed ID: 221540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
    Ambrosi B; Sala C; Bochicchio D; Colombo P; Gazzano G; Fadin C; Morganti A; Faglia G
    Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dose-response relationship of ACTH and cortisol in Cushing's disease.
    Wolfsen AR; Odell WD
    Clin Endocrinol (Oxf); 1980 Jun; 12(6):557-68. PubMed ID: 6249521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
    Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N
    Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.
    Reincke M; Allolio B; Kaulen D; Jaursch-Hancke C; Winkelmann W
    Klin Wochenschr; 1988 Aug; 66(15):686-9. PubMed ID: 2845188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal and abnormal regulation of beta-msh in man.
    Abe K; Nicholson WE; Liddle GW; Orth DN; Island DP
    J Clin Invest; 1969 Aug; 48(8):1580-5. PubMed ID: 4307702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal rhythms of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in normal subjects and in patients with Addison's disease and Cushing's disease.
    Sekiya K; Nawata H; Kato K; Motomatsu T; Ibayashi H
    Endocrinol Jpn; 1986 Oct; 33(5):713-9. PubMed ID: 3030713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of high-dose and low-dose naloxone on plasma ACTH in patients with ACTH hypersecretion.
    Deuss U; Allolio B; Kaulen D; Fischer H; Winkelmann W
    Clin Endocrinol (Oxf); 1985 Mar; 22(3):273-9. PubMed ID: 2983909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion.
    Ambrosi B; Bochicchio D; Riva E; Faglia G
    J Endocrinol Invest; 1983 Aug; 6(4):305-6. PubMed ID: 6315806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma corticotrophin estimations in Addison's disease and following adrenalectomy for Cushing's disease.
    Sirett NE; Purves HD
    J Clin Endocrinol Metab; 1968 Sep; 28(9):1367-9. PubMed ID: 4300562
    [No Abstract]   [Full Text] [Related]  

  • 17. A sensitive direct enzyme immunoassay for cortisol in plasma and saliva.
    Hubl W; Taubert H; Freymann E; Meissner D; Stahl F; Dörner G
    Exp Clin Endocrinol; 1984 Jul; 84(1):63-70. PubMed ID: 6090183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of captopril, an inhibitor of the converting enzyme on naloxone induced secretion of ACTH and LH in man.
    Palermo M; Oliva O; Pala A; Delitala G
    Horm Metab Res; 1993 Oct; 25(10):536-8. PubMed ID: 8262463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsatile luteinizing hormone secretion in patients with Addison's disease. Impact of glucocorticoid substitution.
    Hangaard J; Andersen M; Grodum E; Koldkjaer O; Hagen C
    J Clin Endocrinol Metab; 1998 Mar; 83(3):736-43. PubMed ID: 9506718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New diagnostic tests for Cushing's syndrome: uses of naloxone, vasopressin and alprazolam.
    Jackson RV; Hockings GI; Torpy DJ; Grice JE; Crosbie GV; Walters MM; Strakosch CR
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):579-81. PubMed ID: 8800590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.